Thrombolysis in Acute Myocardial Infarction

作者: A. Betriu , M. Heras , G. Sanz

DOI: 10.1007/978-94-009-1333-2_70

关键词:

摘要: In the past few years we have learned that myocardial infarction is a relatively gradual process can be influenced by several interventions [1]. this regard, reduction of infarct size has been major clinical issue, since amount preserved myocardium will definitely influence outcome patients with [2–5]. Among all aimed at reducing size, recanalization occluded vessel thrombolytic agents generated an increasing interest. Early trials began 25 ago and dealt mainly intravenous streptokinase (SK) [6, 7]. It Rentrop, however, who deserves credit for his remarkable work use intracoronary SK [8, 9], route administration first applied Chazov [10] potentiated later angiographic documentation coronary artery thrombosis as cause acute occlusion [11]. We now gained great deal experience in treatment using either or [12]. Nevertheless, questions regarding therapy evolving remain unsettled. particular, thrombolysis on both long-term mortality, critical time interval intervention to initiated, best drug, its optimal dose administration, management residual stenosis unknown.

参考文章(61)
GRUPPOITALIANOPERLOSTUDIODELL, EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION The Lancet. ,vol. 327, pp. 397- 402 ,(1986) , 10.1016/S0140-6736(86)92368-8
M.L Simoons, M.V/D Brand, C.De Zwaan, F.W.A Verheugt, W.J Remme, P.W Serruys, F Bär, J Res, X.H Krauss, F Vermeer, J Lubsen, IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: A Randomised Trial by the Interuniversity Cardiology Institute in The Netherlands The Lancet. ,vol. 326, pp. 578- 581 ,(1985) , 10.1016/S0140-6736(85)90584-7
K. P. Rentrop, H. Blanke, K. R. Karsch, V. Wiegand, H. Köstering, H. Oster, K. Leitz, Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clinical Cardiology. ,vol. 2, pp. 354- 363 ,(1979) , 10.1002/CLC.4960020507
P. R. Maroko, P. Libby, W. R. Ginks, C. M. Bloor, W. E. Shell, B. E. Sobel, J. Ross, Coronary Artery Reperfusion Journal of Clinical Investigation. ,vol. 51, pp. 2710- 2716 ,(1972) , 10.1172/JCI107090
Johs. Gormsen, B. Tidstrøm, C. Feddersen, J. Ploug, BIOCHEMICAL EVALUATION OF LOW DOSE OF UROKINASE IN ACUTE MYOCARDIAL INFARCTION Acta Medica Scandinavica. ,vol. 194, pp. 191- 198 ,(2009) , 10.1111/J.0954-6820.1973.TB19429.X
Fareed Khaja, Joseph A. Walton, James F. Brymer, Eric Lo, Luis Osterberger, William W. O'Neill, Harry T. Colfer, Robert Weiss, Tennyson Lee, Thomas Kurian, A. David Goldberg, Bertram Pitt, Sidney Goldstein, Intracoronary Fibrinolytic Therapy in Acute Myocardial Infarction New England Journal of Medicine. ,vol. 308, pp. 1305- 1311 ,(1983) , 10.1056/NEJM198306023082201
W J Rogers, J A Mantle, W P Hood, W A Baxley, P L Whitlow, R C Reeves, B Soto, Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction. Circulation. ,vol. 68, pp. 1051- 1061 ,(1983) , 10.1161/01.CIR.68.5.1051
J. Ward Kennedy, James L. Ritchie, Kathryn B. Davis, Michael L. Stadius, Charles Maynard, James K. Fritz, The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction New England Journal of Medicine. ,vol. 312, pp. 1073- 1078 ,(1985) , 10.1056/NEJM198504253121701
Editorial Committee, Paul M. Ness, Toby L. Simon, Christine Cole, Abe Walston, A pilot study of streptokinase therapy in acute myocardial infarction: observations on complications and relation to trial design American Heart Journal. ,vol. 88, pp. 705- 712 ,(1974) , 10.1016/0002-8703(74)90279-8